Invuity, Inc. (IVTY) EPS Estimated At $-0.50

January 13, 2018 - By Michael Collier

 Invuity, Inc. (IVTY) EPS Estimated At $ 0.50

Analysts expect Invuity, Inc. (NASDAQ:IVTY) to report $-0.50 EPS on February, 13.They anticipate $0.06 EPS change or 10.71 % from last quarter’s $-0.56 EPS. After having $-0.52 EPS previously, Invuity, Inc.’s analysts see -3.85 % EPS growth. The stock decreased 1.75% or $0.1 during the last trading session, reaching $5.6. About 64,073 shares traded. Invuity, Inc. (NASDAQ:IVTY) has risen 50.92% since January 13, 2017 and is uptrending. It has outperformed by 34.22% the S&P500.

Invuity, Inc. (NASDAQ:IVTY) Ratings Coverage

Among 4 analysts covering Invuity Inc (NASDAQ:IVTY), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Invuity Inc had 7 analyst reports since August 29, 2016 according to SRatingsIntel. The stock of Invuity, Inc. (NASDAQ:IVTY) earned “Buy” rating by Lake Street on Monday, September 19. As per Wednesday, July 26, the company rating was maintained by Northland Capital. Northland Capital maintained it with “Buy” rating and $1300 target in Tuesday, June 13 report. Craig Hallum initiated Invuity, Inc. (NASDAQ:IVTY) on Monday, August 29 with “Buy” rating. The rating was maintained by Piper Jaffray on Tuesday, July 25 with “Buy”.

Invuity, Inc., a medical technology company, develops various surgical devices to address various surgical procedures in the United States. The company has market cap of $95.98 million. The firm integrates its intelligent photonics technology platform into its single-use and reusable advanced surgical devices to address various critical intracavity illumination and visualization challenges. It currently has negative earnings. It offers various illuminated surgical devices, including Eikon LT Illuminated and Eikon illuminated retractor systems for breast oncology/oncoplastic/general/orthopedics surgeries; Saber Yankauer, a handheld illuminator for orthopedic/spine/cardiothoracic/breast/general surgeries; and Saber Frazier, a handheld illuminator for spine/orthopedic/neurosurgery surgeries.

More notable recent Invuity, Inc. (NASDAQ:IVTY) news were published by: which released: “Invuity Appoints Scott Flora to Board of Directors” on November 21, 2017, also with their article: “Invuity Inc. Showcased PhotonBlade at Premier Inc.’s Annual Breakthroughs …” published on July 12, 2017, published: “Invuity Strengthens Senior Management With Appointment of Chief Human …” on October 17, 2017. More interesting news about Invuity, Inc. (NASDAQ:IVTY) were released by: and their article: “Invuity Announces Full Commercial Launch of PhotonBladeâ„¢” published on September 25, 2017 as well as‘s news article titled: “Invuity to Present at Piper Jaffray Healthcare Conference” with publication date: November 21, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: